» Articles » PMID: 8362771

Time Course of Hemodynamic Changes and Improvement of Exercise Tolerance After Cardioversion of Chronic Atrial Fibrillation Unassociated with Cardiac Valve Disease

Overview
Journal Am J Cardiol
Date 1993 Sep 1
PMID 8362771
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

This study prospectively assessed the time course, magnitude and mechanism of the hemodynamic changes after restoration of sinus rhythm in patients with chronic atrial fibrillation (AF) unassociated with valvular disease. Severe cardiac dysfunction may occur after chronic supraventricular tachycardia in patients with and without underlying cardiac disease. Improvement may follow abolishment of the arrhythmia or adequate slowing of the ventricular rate. Eight patients were studied with a mean previous duration of AF of 10 +/- 9 months. Ejection fraction, exercise capacity and the atrial contribution to the left ventricular filling (only during sinus rhythm) were studied before cardioversion, after cardioversion and 1 week, 1 month and 6 months thereafter. A significant improvement in ejection fraction from 36 +/- 13 to 53 +/- 8% (p < 0.05) occurred at 1 month after cardioversion. Concomitantly, peak oxygen consumption had increased at 1 month, from 20.1 +/- 7 to 25.2 +/- 6 ml/min/kg (p < 0.05). Thereafter, no further improvement in hemodynamic parameters occurred. The atrial systole improved already at 1 week (from 3 +/- 5 to 16 +/- 11%, p < 0.05) and remained unchanged thereafter. Thus, restoration of sinus rhythm was associated with a delayed improvement in ejection fraction and maximal exercise capacity, preceded by an early restoration of atrial contractility and an acute slowing of the heart rate. The discrepancy in time course of restoration of atrial and ventricular function parameters suggests that an intrinsic left ventricular cardiomyopathy is present in patients with AF.

Citing Articles

Predictors of Improvement in Left Ventricular Systolic Dysfunction in Patients with Atrial Fibrillation Undergoing Catheter Ablation: Systematic Review.

Ahluwalia N, Hussain A, Providencia R, Schilling R Arrhythm Electrophysiol Rev. 2025; 14:e02.

PMID: 40017669 PMC: 11865674. DOI: 10.15420/aer.2024.24.


Temporal Association Between Atrial Fibrillation Burden in Cardiac Implantable Electronic Devices and the Risk of Heart Failure Hospitalization.

Ahluwalia N, Koehler J, Sarkar S, Vasudevan N, Majumder S, Landman S Circ Arrhythm Electrophysiol. 2024; 17(8):e012842.

PMID: 38939945 PMC: 11338027. DOI: 10.1161/CIRCEP.124.012842.


Global, regional, and national burden of heart failure associated with atrial fibrillation.

Kularatna S, Jadambaa A, Hewage S, Brain D, McPhail S, Parsonage W BMC Cardiovasc Disord. 2023; 23(1):345.

PMID: 37430216 PMC: 10334524. DOI: 10.1186/s12872-023-03375-9.


Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.

Koniari I, Artopoulou E, Velissaris D, Kounis N, Tsigkas G J Geriatr Cardiol. 2021; 18(5):376-397.

PMID: 34149826 PMC: 8185445. DOI: 10.11909/j.issn.1671-5411.2021.05.003.


Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.

Chourdakis E, Koniari I, Velissaris D, Tsigkas G, Kounis N, Osman N J Geriatr Cardiol. 2021; 18(5):362-375.

PMID: 34149825 PMC: 8185444. DOI: 10.11909/j.issn.1671-5411.2021.05.008.